SMM acknowledges financial support by the Danish Agency for Science, Technology and Innovation, references 09-065736 (Det Strategiske Forskningsrd) and 12-126894 (Technology and Production). == References == == Associated Data == This section collects any data citations, data availability statements, Leuprorelin Acetate or supplementary materials included in this article. == Supplementary Materials ==. respectively, compared with 1, 527 MPa with non-malignant HCV-29 cell-derived exosomes determined by Leuprorelin Acetate QNM AFM. FL3 and T24 exosomes induced endothelial disruption as measured by a decrease in TEER in HUVEC monolayers, whereas no effect was noticed for HCV-29 derived exosomes. FL3 and T24 exosomes traffic more readily (11. 6 and 21. 4% of applied exosomes, respectively) across HUVEC monolayers than HCV-29 derived exosomes (7. 2% of applied exosomes). Malignant cell-derived exosomes activated complement through calcium-sensitive pathways in Leuprorelin Acetate a concentration-dependent manner. == Conclusions == Malignant (metastatic and non-metastatic) cell collection exosomes display a markedly reduced stiffness and adhesion but an increased complement activation compared to non-malignant cell collection exosomes, which may explain the observed increased endothelial monolayer disruption and transendothelial transport of these vesicles. Leuprorelin Acetate Keywords: metastatic cell-derived exosomes, extracellular vesicles, endothelial disruption, complement activation, extravasation, nanomechanical properties Exosomes are nanoscale (50130 nm) extracellular vesicles of endosomal origin detectable in most biological fluids (1, 2). The role of exosomes in intercellular communication is supported by a composition that includes functional miRNA, mRNA, bioactive lipids and proteins (3), whose transfer results in altered phenotypes of the target cells (4). This could have considerable implications in disease conditions, including cancer (5). Tumour-derived exosomes can increase tumour invasiveness and proliferation in an autocrine fashion (6), in addition to interactions with host stromal cells, such as the conversion of fibroblasts to Mouse monoclonal to FUK a myofibroblast phenotype resulting in extracellular matrix (ECM) remodelling that is conducive to tumour growth (7). The presence of matrix metalloproteinases also allows for direct modulation of the ECM by tumour-derived exosomes in the primary tumour microenvironment and metastatic propagate (8). We and others have also demonstrated that exosome secretion may facilitate beneficial exocytosis and cellular removal of tumour suppressors, showing the complex role of exosomes within tumour progression (9, 10). Metastasis is the primary cause of mortality in cancer patients, and it is driven by circulatory tumour cell (CTC) extravasation across endothelium and consequent formation of tissue micrometastasis (11). The release of exosomes into the interstitial space and subsequent dissemination throughout the body highlights a potential role for tumour-derived exosomes in formation of a pre-metastatic niche (12, 13) beyond that of an auto/paracrine action at the primary tumour site. This potential is further supported by increased vascular leakiness and concomitant increased metastatic lesion formation in the lungs of mice after systemic supervision of malignant cell-derived exosomes (14). Factors that contribute to the cellular extravasation across endothelia are poorly understood; mechanical properties and immune interactions, however , may play a role. An increase in paracellular permeability and increased eosinophil migration has been shown to occur as a result of activation of endothelial C5aR, mediated by C5a (15), resulting in cell retraction that suggests a contribution from complement activation. Recent work links chronic intratumoural complement activation to tumour progression. For instance, the measurement of C4d levels in astrocytomas correlated with cancer severity grade (16). Another study in immunocompetent mice bearing a syngeneic tumour offers strongly indicated that intratumoural accumulation of complement activating nanoparticles can accelerate tumour growth through C5a generation (17). The role of C5a liberation and C5a receptor in tumour growth was confirmed in C5 and C5a receptor knock-out animals (17). Collectively these observations may indicate a potential role in intratumoural complement activation by tumour-derived exosomes in tumour growth. This work investigates the mechanical properties using atomic force microscopy (AFM), complement activation and the effect on endothelial integrity and transport across a primary endothelial cell barrier model of non-malignant, isogenic malignant metastatic and malignant non-metastatic cell-derived exosomes..